Short Interest in Columbia Research Enhanced Value ETF (NYSEARCA:REVS) Expands By 61.3%

Columbia Research Enhanced Value ETF (NYSEARCA:REVS) saw a significant increase in short interest in the month of August. As of August 14th, there was short interest totaling 44,970 shares, an increase of 61.3% from the July 30th total of 27,888 shares. Approximately 0.4% of the company’s stock are sold short. Based on an average daily volume of 41,985 shares, the short-interest ratio is currently 1.1 days.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of REVS. Ruggaard & Associates LLC boosted its stake in Columbia Research Enhanced Value ETF by 0.6% during the first quarter. Ruggaard & Associates LLC now owns 52,425 shares of the company’s stock worth $1,500,000 after acquiring an additional 322 shares in the last quarter. Private Advisor Group LLC grew its holdings in Columbia Research Enhanced Value ETF by 2.2% in the first quarter. Private Advisor Group LLC now owns 42,408 shares of the company’s stock worth $1,214,000 after purchasing an additional 922 shares during the period. Western Wealth Management LLC bought a new position in shares of Columbia Research Enhanced Value ETF during the first quarter valued at approximately $29,000. Steward Partners Investment Advisory LLC bought a new position in shares of Columbia Research Enhanced Value ETF during the fourth quarter valued at approximately $37,000. Finally, Commonwealth Equity Services LLC lifted its holdings in shares of Columbia Research Enhanced Value ETF by 14.8% during the fourth quarter. Commonwealth Equity Services LLC now owns 24,788 shares of the company’s stock valued at $701,000 after purchasing an additional 3,191 shares during the last quarter.

Columbia Research Enhanced Value ETF Trading Down 0.6%

REVS traded down $0.22 during trading on Monday, reaching $33.88. The stock had a trading volume of 39,659 shares, compared to its average volume of 51,599. The company has a market capitalization of $338.80 million, a price-to-earnings ratio of 16.41 and a beta of 0.79. The stock’s 50 day moving average is $33.05 and its two-hundred day moving average is $31.14. Columbia Research Enhanced Value ETF has a one year low of $27.24 and a one year high of $34.23.

Columbia Research Enhanced Value ETF Company Profile

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.